Cargando…
TOX Expression in Mycosis Fungoides and Sezary Syndrome
Mycosis fungoides (MF) and Sezary syndrome (SS) are the two most common type of cutaneous T-cell lymphoma (CTCL). Currently, no markers can be clearly related to prognosis or to differential diagnosis between early stages and inflammatory benign diseases (IBD). The thymocyte selection-associated hig...
Autores principales: | Pileri, Alessandro, Cavicchi, Martina, Bertuzzi, Clara, Righi, Simona, Zengarini, Corrado, Sabattini, Elena, Roncador, Giovanna, Agostinelli, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316398/ https://www.ncbi.nlm.nih.gov/pubmed/35885488 http://dx.doi.org/10.3390/diagnostics12071582 |
Ejemplares similares
-
The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications
por: Pileri, Alessandro, et al.
Publicado: (2021) -
Mycosis fungoides and Sézary syndrome
por: Jonak, Constanze, et al.
Publicado: (2021) -
Mycosis fungoides and Sézary syndrome
por: Lee, Hyewon
Publicado: (2023) -
The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015) -
Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides
por: Mascolo, Massimo, et al.
Publicado: (2020)